CARD10 and neoplasm: Previous studies have demonstrated that CARMA3 mediates the activation of G protein-coupled receptors and receptor tyrosine kinases (RTKs) in tumor pathogenesis 21 a, and its expression has also been linked to Nrf2 activation in pancreatic cancer 27.